
Fully Human Antibodies, Acceleration of Discovery & Development
Mission
Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release
Breaking News


Individual Project Design, Fee for Service or Milestone-based
Contract Research, R&D Services
Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release
Breaking News


Partnered R&D, Collaborations, Licensing
Pipeline & Partnering
Ymmunobio signs collaboration agreement with YUMAB
Swiss biotech company to accelerate its cancer drug development programme.
Read press release
Breaking News
